Patent details

Basic Information

Publication number:

EP1086076

PCT Application Number:

PCT/US/1999/013744

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP999287691

PCT Publication Number:

WO/1999/065870

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

SULFONAMIDE INHIBITORS OF ASPARTYL PROTEASE

French Title of Invention:

INHIBITEURS SULFONAMIDES D'ASPARTYLE PROTEASE

German Title of Invention:

SULFONAMIDE ALS ASPARTYL-PROTEASE-INHIBITOREN

SPC Number:

Dates

Filing date:

17/06/1999

Grant date:

22/12/2004

EP Publication Date:

22/12/2004

PCT Publication Date:

23/12/1999

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

28/03/2001

EP B1 Publication Date:

22/12/2004

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

17/06/2006

Expiration date:

17/06/2019

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

17/06/1999

 

 

Name:

VERTEX PHARMACEUTICALS INCORPORATED

Address:

130 Waverly Street, Cambridge, MA 02139-4242, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

02/03/2005

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

ANDREWS Clarence W., III, Glaxo Wellcome Inc.

Address:

United States (US)

2

Name:

HALE Michael, R.

Address:

United States (US)

3

Name:

SPALTENSTEIN Andrew, Glaxo Wellcome Inc.

Address:

United States (US)

4

Name:

FURFINE Eric Steven, Glaxo Wellcome Inc.

Address:

United States (US)

5

Name:

LOWEN Gregory, Thomas

Address:

United States (US)

6

Name:

SHERRILL Ronald George, Glaxo Wellcome Inc.

Address:

United States (US)

Priority

Priority Number:

90094 P

Priority Date:

19/06/1998

Priority Country:

United States (US)

Classification

Main IPC Class:

C07C 303/00;

Filing date	Document type	Number of pages